Avid Bioservices Inc (CDMO)

[geocappy1]

Thank you for your perspective which some of us tried to say but w/o medical backgrounds. If the treatment arm had a better ORR and PFS then it would stand to reason that control arm patients would seek approved I/O options earlier as they failed to respond. This would lead to control patients getting additional drugs sooner. Heck, I bet if we let the control arm get treated with bavi after 1st getting the placebo for some time their survival numbers would also be similar to the treatment group. Dah.

Therein lies the argument for reviewing data, followup, etc and possibly construct g an argument to the FDA